Efficacy of ubrogepant for the treatment of migraine symptoms during the prodrome (premonitory phase): Results from the prodrome trial

Authors
Category Primary study
JournalJOURNAL OF THE NEUROLOGICAL SCIENCES
Year 2023
This article has no abstract
Epistemonikos ID: b5b828d9edb246f01e39361c5444d033e3d9f544
First added on: Feb 29, 2024